Julius Knowles - Jun 4, 2021 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Stock symbol
KROS
Transactions as of
Jun 4, 2021
Transactions value $
-$952,613
Form type
4
Date filed
6/8/2021, 04:31 PM
Previous filing
Jun 3, 2021
Next filing
Jul 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Sale -$141K -2.99K -0.54% $47.23 552K Jun 4, 2021 See footnote F1, F2, F3
transaction KROS Common Stock Sale -$92.1K -1.95K -0.52% $47.23 370K Jun 4, 2021 See footnote F1, F2, F4
transaction KROS Common Stock Sale -$49K -1.02K -0.18% $48.15 551K Jun 4, 2021 See footnote F1, F3, F5
transaction KROS Common Stock Sale -$31.9K -663 -0.18% $48.15 369K Jun 4, 2021 See footnote F1, F4, F5
transaction KROS Common Stock Sale -$32.7K -703 -0.13% $46.48 551K Jun 7, 2021 See footnote F1, F3, F6
transaction KROS Common Stock Sale -$21.3K -459 -0.12% $46.48 369K Jun 7, 2021 See footnote F1, F4, F6
transaction KROS Common Stock Sale -$37.2K -786 -0.14% $47.34 550K Jun 7, 2021 See footnote F1, F3, F7
transaction KROS Common Stock Sale -$24.2K -512 -0.14% $47.34 368K Jun 7, 2021 See footnote F1, F4, F7
transaction KROS Common Stock Sale -$27.3K -560 -0.1% $48.76 549K Jun 7, 2021 See footnote F1, F3, F8
transaction KROS Common Stock Sale -$17.8K -366 -0.1% $48.76 368K Jun 7, 2021 See footnote F1, F4, F8
transaction KROS Common Stock Sale -$43.5K -870 -0.16% $50.02 548K Jun 7, 2021 See footnote F1, F3, F9
transaction KROS Common Stock Sale -$28.4K -568 -0.15% $50.02 368K Jun 7, 2021 See footnote F1, F4, F9
transaction KROS Common Stock Sale -$202K -3.97K -0.72% $50.80 544K Jun 7, 2021 See footnote F1, F3, F10
transaction KROS Common Stock Sale -$131K -2.59K -0.7% $50.80 365K Jun 7, 2021 See footnote F1, F4, F10
transaction KROS Common Stock Sale -$44.2K -858 -0.16% $51.46 543K Jun 7, 2021 See footnote F1, F3, F11
transaction KROS Common Stock Sale -$28.8K -560 -0.15% $51.46 364K Jun 7, 2021 See footnote F1, F4, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.90 to $47.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8), (9), (10) and (11).
F3 The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF I.
F4 The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.90 to $48.57 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.89 to $46.83 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.89 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.25 to $49.24 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.28 to $50.27 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.28 to $51.265 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.31 to $51.80 inclusive.